• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施血脂异常管理指南对初级保健中缺血性心脏病二级预防的胆固醇控制的影响。

Impact of Implementing a Dyslipidemia Management Guideline on Cholesterol Control for Secondary Prevention of Ischemic Heart Disease in Primary Care.

机构信息

Equip d'Atenció Primària Tortosa Oest, Institut Català de la Salut, 43500 Tortosa, Tarragona, Spain.

Programa de Doctorat en Medicina, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

出版信息

Int J Environ Res Public Health. 2020 Nov 19;17(22):8590. doi: 10.3390/ijerph17228590.

DOI:10.3390/ijerph17228590
PMID:33228008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7699273/
Abstract

Cardiovascular diseases (CVD) are the main cause of death worldwide. The control of CVD risk factors, such as dyslipidemia, reduces their mortality rate. Nonetheless, fewer than 50% of patients with ischemic heart disease (IHD) have good cholesterol control. Our objective is to assess whether the level of participation of general practitioners (GPs) in activities to implement a dyslipidemia management guideline, and the characteristics of the patient and physician are associated with cholesterol control in IHD patients. We undertook a quasi-experimental, uncontrolled, before-and-after study of 1151 patients. The intervention was carried out during 2010 and 2011, and consisted of a face-to-face training and online course phase (Phase 1), and another of face-to-face feedback (Phase 2). The main outcome variable was the low-density lipoprotein cholesterol (LDL-C) control, whereby values of <100 mg/dL (2.6 mmol/L) were set as a good level of control, according to the recommendations of the guidelines in force in 2009. After Phase 1, 6.7% more patients demonstrated good cholesterol control. With respect to patient characteristics, being female and being older were found to be risk factors of poor control. Being diabetic and having suffered a stroke were protective factors. Of the GPs' characteristics, being tutor in a teaching center for GP residents and having completed the online course were found to be protective factors. We concluded that cholesterol control in IHD patients was influenced by the type of training activity undertook by physicians during the implementation of the GPC, and patient and physician characteristics. We highlight that if we apply the recent targets of the European guideline, which establish a lower level of LDL-C control, the percentage of good control could be worse than the observed in this study.

摘要

心血管疾病 (CVD) 是全球主要的死亡原因。控制 CVD 风险因素,如血脂异常,可以降低死亡率。然而,仅有不到 50%的缺血性心脏病 (IHD) 患者胆固醇控制良好。我们的目的是评估全科医生 (GP) 参与实施血脂异常管理指南的活动水平,以及患者和医生的特征是否与 IHD 患者的胆固醇控制有关。我们进行了一项准实验、非对照、前后对照研究,共纳入了 1151 名患者。干预措施于 2010 年和 2011 年进行,包括面对面培训和在线课程阶段 (第 1 阶段),以及另一个面对面反馈阶段 (第 2 阶段)。主要结局变量是低密度脂蛋白胆固醇 (LDL-C) 的控制情况,根据 2009 年现行指南的建议,将 <100mg/dL(2.6mmol/L)的 LDL-C 设定为良好控制水平。第 1 阶段后,有 6.7%的患者显示出良好的胆固醇控制。就患者特征而言,女性和年龄较大是控制不良的危险因素。糖尿病和中风史是保护因素。在医生特征方面,担任全科医生住院医师教学中心的导师和完成在线课程被认为是保护因素。我们得出结论,IHD 患者的胆固醇控制受到医生在实施 GPC 期间所进行的培训活动类型以及患者和医生特征的影响。我们强调,如果我们应用欧洲指南的最新目标,即建立更低的 LDL-C 控制水平,那么良好控制的比例可能比本研究中观察到的更差。

相似文献

1
Impact of Implementing a Dyslipidemia Management Guideline on Cholesterol Control for Secondary Prevention of Ischemic Heart Disease in Primary Care.实施血脂异常管理指南对初级保健中缺血性心脏病二级预防的胆固醇控制的影响。
Int J Environ Res Public Health. 2020 Nov 19;17(22):8590. doi: 10.3390/ijerph17228590.
2
Lipid-lowering drugs in ischaemic heart disease: a quasi-experimental uncontrolled before-and-after study of the effectiveness of clinical practice guidelines.缺血性心脏病中的降脂药物:临床实践指南有效性的准实验性无对照前后研究。
BMC Cardiovasc Disord. 2011 Aug 4;11:47. doi: 10.1186/1471-2261-11-47.
3
Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.心血管二级预防护理新指南的实施:一项随机对照试验的亚组分析
BMC Cardiovasc Disord. 2016 Apr 30;16:77. doi: 10.1186/s12872-016-0252-0.
4
[Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].[接受降脂治疗的血脂异常患者动脉粥样硬化性心血管疾病一级和二级预防中胆固醇目标达成情况:中国血脂异常防治研究(DYSIS-China)亚组分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Aug 24;44(8):665-70. doi: 10.3760/cma.j.issn.0253-3758.2016.08.006.
5
Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population.根据 1560 万人群的低密度脂蛋白胆固醇水平,探讨高甘油三酯血症对心血管死亡率的影响。
Eur J Prev Cardiol. 2024 Feb 15;31(3):280-290. doi: 10.1093/eurjpc/zwad330.
6
Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.缺血性中风高危患者的指南导向低密度脂蛋白管理:来自“遵循指南-中风2003至2012”的研究结果
Stroke. 2014 Nov;45(11):3343-51. doi: 10.1161/STROKEAHA.114.006736. Epub 2014 Oct 9.
7
The association between processes, structures and outcomes of secondary prevention care among VA ischemic heart disease patients.退伍军人事务部缺血性心脏病患者二级预防护理的过程、结构与结果之间的关联。
BMC Cardiovasc Disord. 2006 Feb 9;6:6. doi: 10.1186/1471-2261-6-6.
8
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
9
[Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].[使用他汀类药物治疗的糖尿病患者的血脂异常。斯皮安地区DYSIS研究结果]
Med Clin (Barc). 2013 Nov 16;141(10):430-6. doi: 10.1016/j.medcli.2012.09.030. Epub 2012 Dec 12.
10
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis.血脂异常、冠状动脉钙和动脉粥样硬化性心血管疾病的发生:来自动脉粥样硬化多民族研究的他汀类药物治疗意义。
Circulation. 2014 Jan 7;129(1):77-86. doi: 10.1161/CIRCULATIONAHA.113.003625. Epub 2013 Oct 20.

引用本文的文献

1
Exploring the implemented guidelines for dyslipidemia treatment and care among nurses and physicians: A qualitative study in Jordan.探索护士和医生中血脂异常治疗与护理的实施指南:约旦的一项定性研究。
PLoS One. 2025 Aug 7;20(8):e0319126. doi: 10.1371/journal.pone.0319126. eCollection 2025.

本文引用的文献

1
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.欧盟范围内二级和初级保健中使用调脂治疗的横断面观察性研究:DA VINCI 研究。
Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047.
2
Sex and gender: modifiers of health, disease, and medicine.性别与健康、疾病和医学。
Lancet. 2020 Aug 22;396(10250):565-582. doi: 10.1016/S0140-6736(20)31561-0.
3
Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study.澳门基层医疗环境中血脂异常管理审核项目的有效性:一项质量改进研究。
Fam Med Community Health. 2020 Feb 24;8(1):e000222. doi: 10.1136/fmch-2019-000222. eCollection 2020.
4
Effectiveness of electronic point-of-care reminders versus monthly feedback to improve adherence to 10 clinical recommendations in primary care: a cluster randomized clinical trial.电子即时提醒与每月反馈对改善初级保健中 10 项临床推荐依从性的效果:一项群组随机临床试验。
BMC Med Inform Decis Mak. 2019 Nov 29;19(1):245. doi: 10.1186/s12911-019-0976-8.
5
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
6
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会/美国预防医学学会/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国临床内分泌医师协会/美国国家脂质协会/美国初级保健医师学会血胆固醇管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209. doi: 10.1016/j.jacc.2018.11.002. Epub 2018 Nov 10.
7
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会(JAS)2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
8
Results from the CLUES study: a cluster randomized trial for the evaluation of cardiovascular guideline implementation in primary care in Spain.CLUES研究结果:一项用于评估西班牙初级保健中心血管指南实施情况的整群随机试验。
BMC Health Serv Res. 2018 Feb 8;18(1):93. doi: 10.1186/s12913-018-2863-x.
9
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南。
Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):115. doi: 10.1016/j.rec.2017.01.002.
10
Sex and gender differences in therapy of type 2 diabetes.2型糖尿病治疗中的性别差异
Diabetes Res Clin Pract. 2017 Sep;131:230-241. doi: 10.1016/j.diabres.2017.07.012. Epub 2017 Jul 13.